Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US Eylea Biosimilar Approvals Set Up Competition On Aflibercept
Both Biocon And Biogen Receive Interchangeability Designations For Ophthalmic Treatment
May 21 2024
•
By
David Wallace
Biocon and Biogen have US approvals for aflibercept • Source: Shutterstock
More from Biosimilars
More from Products